EU \/ Bulgaria \u00b7 poultry farming and veterinary control \u00b7 adopted act \u00b7 new development<\/p>\n
Implementing Decision (EU) 2026\/2395 published on 26 October adds protection and surveillance zones around a new outbreak of highly pathogenic avian influenza in the Stara Zagora district. Restrictions have also been extended for three outbreaks in the Plovdiv district due to the later completion of cleaning and disinfection. For Rakovski, the protection measures are foreseen until at least 3 November, and for the new outbreak around Elenino and Hristiyanovo \u2014 until 21 November, with subsequent surveillance until 30 November. Farms, transporters and traders must check the specific site and route against the current annex and national measures. The expiry of a specified date does not automatically mean a permit to move.<\/p>\n
EU \/ Singapore \u00b7 pharmacy and GMP \u00b7 adopted act \u00b7 regulatory equivalence<\/p>\n
By Implementing Decision (EU) 2026\/2347, the European Commission adds Singapore to the list of third countries with an equivalent regulatory framework for active substances for medicinal products for human use. The act was published on 26 October and will enter into force on 15 November 2026. The decision follows a documentary assessment and an on-site visit, including observation of inspections in March. For European importers and manufacturers, this is a reason to review the documentary requirements for suppliers and the evidence of regulatory supervision. The recognition concerns the specified control system; it does not constitute an authorisation for an individual medicinal product and does not waive the need for qualification of suppliers and compliance with applicable GMP requirements.<\/p>\n
EU \u00b7 plant protection and market access \u00b7 adopted regulation \u00b7 transitional periods<\/p>\n
Implementing Regulation (EU) 2026\/2348, published on 26 October, extends the approval periods of a number of active substances for plant protection products until the renewal procedures are completed. The act enters into force on 29 October 2026, and the new expiry dates vary for each substance. For example, buprofezin is set at 15 March 2027, and for amidosulfuron at 31 August 2027. Authorisation holders, suppliers and farms should update their substance- and product-specific registers. The extension is not a definitive renewal, does not replace national product authorisations and does not in itself change the permitted residue levels in food.<\/p>\n
USA \u00b7 maritime transport and personnel competence \u00b7 current rule \u00b7 new stage<\/p>\n
The U.S. Coast Guard\u2019s final rule for personnel on U.S.-flagged passenger ships carrying more than 12 passengers on international voyages will take effect on October 26, 2026. It requires familiarization with passenger ship emergency procedures and expands the scope of passenger management training for certain categories of seafarers. Operators and crews must have evidence of the training conducted available upon inspection. For Bulgarian manning agencies and training centers, the practical step is a comparison of positions, programs, and records with U.S. requirements. This is a new stage under the September 25 act, not a new universal obligation for all ships.<\/p>\n
United States \u00b7 nuclear energy and technical demonstration \u00b7 final rule \u00b7 future implementation<\/p>\n
On October 26, the U.S. Nuclear Regulatory Commission published final amendments that allow the licensing of commercial reactors to use relevant information from previously authorized federal reactor designs. The rule goes into effect on November 25, 2026, and applies to facilities that have been tested and demonstrated to be capable of safe operation. The applicant must explain how the characteristics of the previous authorization satisfy the NRC\u2019s requirements. For developers and international engineering providers, this means carefully structuring test results, design rationale, and traceability of evidence. A previous federal authorization does not automatically translate into a license for commercial operation.<\/p>\n
Bulgaria \u00b7 agriculture, certification and laboratories \u00b7 consulting \u00b7 T\u20137<\/p>\n
The public consultation on the draft amendments to the Act on Seed and Propagating Material ends on 2 November 2026. This is a reminder with seven days remaining, not a new law: the draft was published on 1 October. The proposed Articles 57\u201359 specify certificates and labels for imports, including OECD and ISTA documents for the relevant categories, as well as laboratory checks based on risk analysis. Importers, suppliers and laboratories should check the traceability between batches and accompanying documents, the envisaged exceptions and the practical feasibility of the deadlines. The remaining week allows for specific difficulties and proposals to be presented to the Ministry of Agriculture and Food.<\/p>\n
USA \u00b7 medical devices and manufacturer assessment \u00b7 consultation \u00b7 T\u20137<\/p>\n
FDA is accepting comments on the continuation of the Voluntary Improvement Program for eligible medical device manufacturers through November 2, 2026. This reminder comes with seven days remaining before the November 2 deadline set out in the October 1 notice. The program uses independent assessments of organizational capabilities and performance facilitated by the Medical Device Innovation Consortium, but the consultation is about information sharing and administrative burden. It does not create a new mandatory certification scheme and does not replace applicable regulatory requirements. Manufacturers and evaluators should review what data is being provided, who is accountable, and whether the efforts described reflect real-world practice before submitting a comment.<\/p>\n
Canada \u00b7 OHS and standardized first aid kits \u00b7 consultation \u00b7 T\u20137<\/p>\n
The Canadian draft to harmonize workplace first aid kits through the CSA Z1220 standard is open for comments until November 2, 2026. The proposal was published on October 3 and proposes changes to five Canada Labour Code regimes applicable to federally regulated employers. It affects the composition and selection of kits, but is not yet a new requirement. Suppliers to the Canadian market and international organizations with local operations will find it useful to compare their product specifications, risk assessment and internal OH&S procedures with the draft. The remaining seven days provide an opportunity to point out practical difficulties without automatically assuming mandatory certification of every kit.<\/p>\n
USA \/ international sector \u00b7 nuclear facilities and testing \u00b7 international strategic signal \u00b7 confirmed direction<\/p>\n
On October 26, the NRC confirmed the final status of Regulatory Guide 1.220, Revision 0, for the Acceptability of the ASME OM-2 Code for Testing Components in Nuclear Facilities. The guidance adopts the 2024 edition with the regulatory positions as the approach for developing and implementing in-service testing programs. It is effective August 18, 2026; today\u2019s notice confirms that no significant adverse comments have been received requiring change. It is important for engineering providers and testing organizations to verify the specific acceptance conditions and compliance of their procedures. This does not automatically make the code mandatory for every facility or legally enforceable in the EU.<\/p>\n
USA \u00b7 automobiles, components and testing laboratories \u00b7 consultation \u00b7 draft technical rule<\/p>\n
The US NHTSA published on 26 October a draft amendment to FMVSS No. 108 on automotive lighting, with comments due by 25 November 2026. The proposal concerns test conditions for certain headlamps and design limitations, as well as controls and indicators for vehicles with automated driving systems without manual controls. Voluntary light markings for such systems are also being discussed. This is a draft, not a new, effective technical obligation. Vehicle and component manufacturers, as well as test laboratories, should align the affected procedures and product configurations with the proposal. The US process does not automatically change the EU type-approval requirements.<\/p>\n
Published by MG Global in partnership with ERPI.<\/p>","protected":false},"excerpt":{"rendered":"
\u041d\u043e\u0432\u043e \u0440\u0430\u0437\u0432\u0438\u0442\u0438\u0435 \u041d\u043e\u0432\u0438 \u0438 \u0443\u0434\u044a\u043b\u0436\u0435\u043d\u0438 \u0437\u043e\u043d\u0438 \u0437\u0430 \u0438\u043d\u0444\u043b\u0443\u0435\u043d\u0446\u0430 \u043f\u043e \u043f\u0442\u0438\u0446\u0438\u0442\u0435 \u0432 \u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f \u0415\u0421 \/ \u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f \u00b7 \u043f\u0442\u0438\u0446\u0435\u0432\u044a\u0434\u0441\u0442\u0432\u043e \u0438 \u0432\u0435\u0442\u0435\u0440\u0438\u043d\u0430\u0440\u0435\u043d \u043a\u043e\u043d\u0442\u0440\u043e\u043b \u00b7 \u043f\u0440\u0438\u0435\u0442 \u0430\u043a\u0442 \u00b7 \u043d\u043e\u0432\u043e \u0440\u0430\u0437\u0432\u0438\u0442\u0438\u0435 \u041f\u0443\u0431\u043b\u0438\u043a\u0443\u0432\u0430\u043d\u043e\u0442\u043e \u043d\u0430 26 \u043e\u043a\u0442\u043e\u043c\u0432\u0440\u0438 \u0420\u0435\u0448\u0435\u043d\u0438\u0435 \u0437\u0430 \u0438\u0437\u043f\u044a\u043b\u043d\u0435\u043d\u0438\u0435 (\u0415\u0421) 2026\/2395 \u0434\u043e\u0431\u0430\u0432\u044f \u0437\u0430\u0449\u0438\u0442\u043d\u0438 \u0438 \u043d\u0430\u0434\u0437\u043e\u0440\u043d\u0438 \u0437\u043e\u043d\u0438 \u043e\u043a\u043e\u043b\u043e \u043d\u043e\u0432\u043e \u043e\u0433\u043d\u0438\u0449\u0435 \u043d\u0430 \u0432\u0438\u0441\u043e\u043a\u043e\u043f\u0430\u0442\u043e\u0433\u0435\u043d\u043d\u0430 \u0438\u043d\u0444\u043b\u0443\u0435\u043d\u0446\u0430 \u043f\u043e \u043f\u0442\u0438\u0446\u0438\u0442\u0435 \u0432 \u043e\u0431\u043b\u0430\u0441\u0442 \u0421\u0442\u0430\u0440\u0430 \u0417\u0430\u0433\u043e\u0440\u0430. \u0423\u0434\u044a\u043b\u0436\u0435\u043d\u0438 \u0441\u0430 \u0438 […]<\/p>\n","protected":false},"author":7,"featured_media":46333,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[42],"class_list":["post-46501","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-moody-news-daily"],"_links":{"self":[{"href":"https:\/\/mgglobal.eu\/en\/wp-json\/wp\/v2\/posts\/46501","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mgglobal.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mgglobal.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mgglobal.eu\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/mgglobal.eu\/en\/wp-json\/wp\/v2\/comments?post=46501"}],"version-history":[{"count":1,"href":"https:\/\/mgglobal.eu\/en\/wp-json\/wp\/v2\/posts\/46501\/revisions"}],"predecessor-version":[{"id":46502,"href":"https:\/\/mgglobal.eu\/en\/wp-json\/wp\/v2\/posts\/46501\/revisions\/46502"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mgglobal.eu\/en\/wp-json\/wp\/v2\/media\/46333"}],"wp:attachment":[{"href":"https:\/\/mgglobal.eu\/en\/wp-json\/wp\/v2\/media?parent=46501"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mgglobal.eu\/en\/wp-json\/wp\/v2\/categories?post=46501"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mgglobal.eu\/en\/wp-json\/wp\/v2\/tags?post=46501"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}